This HTML5 document contains 12 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

PrefixNamespace IRI
dbpedia-owlhttp://dbpedia.org/ontology/
foafhttp://xmlns.com/foaf/0.1/
rdfshttp://www.w3.org/2000/01/rdf-schema#
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
n6http://commons.wikimedia.org/wiki/Special:FilePath/Vismodegib2DACS.
dbpediahttp://dbpedia.org/resource/
n7http://commons.wikimedia.org/wiki/Special:FilePath/Vismodegib2DACS.svg?width=
Subject Item
dbpedia:Vismodegib
rdfs:comment
Vismodegib (trade name Erivedge) is a drug for the treatment of basal-cell carcinoma (BCC). The approval of vismodegib on January 30, 2012, represents the first Hedgehog signaling pathway targeting agent to gain U.S. Food and Drug Administration (FDA) approval. The drug is also undergoing clinical trials for metastatic colorectal cancer, small-cell lung cancer, advanced stomach cancer, pancreatic cancer, medulloblastoma and chondrosarcoma as of June 2011.
foaf:depiction
n6:svg
dbpedia-owl:atcPrefix
L01
dbpedia-owl:atcSuffix
XX43
dbpedia-owl:bioavailability
31.8
dbpedia-owl:casNumber
879085-55-9
dbpedia-owl:chEBI
66903
dbpedia-owl:drugbank
DB08828
dbpedia-owl:fdaUniiCode
25X868M3DS
dbpedia-owl:iupacName
2-Chloro-N-(4-chloro-3-pyridin-2-ylphenyl)-4-methylsulfonylbenzamide
dbpedia-owl:pubchem
24776445
dbpedia-owl:thumbnail
n7:300